Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Leukemia|December 18, 2009
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysisL Bullinger, J Krönke, C Schön, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2004
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia IntergroupR F Schlenk, A Benner, J Krauter, et al.Leukemia|December 14, 2012
Cell of origin determines clinically relevant subtypes of MLL-rearranged AMLA V Krivtsov, M E Figueroa, A U Sinha, et al.Leukemia|July 20, 2012
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevanceF G Rücker, A C Russ, S Cocciardi, et al.Leukemia|July 30, 2003
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trialR F Schlenk, A Benner, F Hartmann, et al.Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.Leukemia|June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in miceA J Deshpande, A Rouhi, Y Lin, et al.Leukemia|July 28, 2023
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trialJ Hammersen, S Birndt, K Döhner, et al.Leukemia|August 10, 2011
Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemiaF Damm, T Bunke, F Thol, et al.Leukemia|April 22, 2005
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemiaR F Schlenk, U Germing, F Hartmann, et al.Pageof 4